Patent details
EP2536752 Title: Modified recombinant Factor VIII
Basic Information
- Publication number:
- EP2536752
- PCT Application Number:
- PCT/EP/2011/051889
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP117084194
- PCT Publication Number:
- WO/2011/101277
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Modified recombinant Factor VIII
- French Title of Invention:
- Facteur VIII, modfié et recombiné
- German Title of Invention:
- Modifizierter, rekombinanter Faktor VIII
- SPC Number:
Dates
- Filing date:
- 09/02/2011
- Grant date:
- 08/04/2015
- EP Publication Date:
- 08/04/2015
- PCT Publication Date:
- 25/08/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/12/2012
- EP B1 Publication Date:
- 08/04/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/02/2016
- Expiration date:
- 09/02/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/02/2011
- Name:
- Novo Nordisk A/S
- Address:
- Novo Allé, 2880 Bagsværd, Denmark (DK)
Inventor
1
- Name:
- BUCHARDT Jens
- Address:
- Denmark (DK)
2
- Name:
- BEHRENS Carsten
- Address:
- Denmark (DK)
Priority
1
- Priority Number:
- 10153716
- Priority Date:
- 16/02/2010
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 305723 P
- Priority Date:
- 18/02/2010
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 14/755;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|